Restricted accessLetterFirst published online 2024-8
Reply to Letter: “The Value of Systemic-Immune Inflammatory Response Index in Predicting Contrast-Induced Nephropathy in Patients With ST-Elevation Myocardial Infarction”
MoD-G. The value of systemic-immune inflammatory response index in predicting contrast-induced nephropathy in patients with st-elevation myocardial infarction. Angiology. 2024;75:698.
2.
ŞaylıkFÇınarTSarıkayaRTanboğaİH. Development and validation of nomogram based on the systemic-immune inflammation response index for predicting contrast-induced nephropathy in ST-elevation myocardial infarction patients. Angiology. 2024;75:673-681.
3.
ÖztürkRİnanDGüngörB. Systemic immune-inflammation index is a predictor of contrast-induced nephropathy in patients with ST-Segment elevation myocardial infarction. Angiology. 2022;73:125-131.
4.
KayaAKayaYTopçuSGünaydınKurtTanboğa, et al.Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65:51-56.
5.
SatilmisSKarabulutA. Value of C-reactive protein/albumin ratio in predicting the development of contrast-induced nephropathy in patients with non-ST elevation myocardial infarction. Angiology. 2020;71:366-371.
